Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Oncology Practice|May 16, 2017
Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced AnemiaVirginia Noxon, Kevin B Knopf, LeAnn B Norris, et al.Cancer Medicine|June 22, 2017
Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR)Rachel A Sabol, Virginia Noxon, Oliver Sartor, et al.The Lancet. Oncology|November 8, 2016
Generic oncology drugs: are they all safe?Y Tony Yang, Sumimasa Nagai, Brian K Chen, et al.Journal of General Internal Medicine|June 14, 2012
Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR)Charles L Bennett, Karen M Starko, Henrik S Thomsen, et al.Cancer|April 29, 2014
Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) projectKenneth R Carson, Scott D Newsome, Ellen J Kim, et al.The Oncologist|March 8, 2019
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and CanadaBrian Chen, Sumimasa Nagai, James O Armitage, et al.The Journal of Community and Supportive Oncology|March 9, 2016
Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social networkKamaljeet Kaur, Raja Fayad, Arpit Saxena, et al.Pageof 2